Fight Over Waze? Way
Health Care: Drugs
GTx Inc. (GTXI: NASDAQ)
$5.89 -0.59 | -9.10%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 48.04M | 63.74M | 58.18M | 40.22M |
| Receivables | 9.00K | 981.00K | 683.00K | 595.00K |
| Inventories | 0.00 | 161.00K | 171.00K | 116.00K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 56.82M | 76.85M | 60.36M | 50.68M |
| Property, Plant & Equipment, Gross | 9.27M | 9.20M | 9.18M | 9.78M |
| Accumulated Depreciation & Depletion | 8.76M | 8.11M | 7.14M | 6.49M |
| Property, Plant & Equipment, Net | 507.00K | 1.10M | 2.04M | 3.29M |
| Intangibles | 452.00K | 240.00K | 1.85M | 3.76M |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Assets | 959.00K | 1.34M | 3.89M | 7.05M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 57.77M | 78.18M | 64.25M | 57.72M |
| Accounts Payable | 1.71M | 1.22M | 848.00K | 1.27M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 9.50M | 6.08M | 5.30M | 15.95M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 578.00K | 234.00K | 7.22M | 50.52M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 578.00K | 234.00K | 7.22M | 50.52M |
| Total Liabilities | 10.07M | 6.31M | 12.52M | 66.47M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 47.70M | 71.87M | 51.73M | -8.75M |
| Common Par | 63.00K | 63.00K | 52.00K | 36.00K |
| Additional Paid In Capital | 460.89M | 457.98M | 404.56M | 359.39M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -413.25M | -386.17M | -352.88M | -368.17M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 47.70M | 71.87M | 51.73M | -8.75M |
| Total Equity | 47.70M | 71.87M | 51.73M | -8.75M |
| Total Liabilities & Stock Equity | 57.77M | 78.18M | 64.25M | 57.72M |
| Total Common Shares Outstanding | 62.82M | 62.79M | 51.72M | 36.42M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 62.81M | 57.36M | 38.87M | 36.42M |
| Diluted Weighted Shares Outstanding | 62.81M | 57.36M | 38.87M | 36.42M |
| Number of Employees | 88 | 90 | 111 | 120 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with GTXI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserJRC'S PICKS
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- ContributorStocks With Big Insider Buy...
- Contributor10 Cheap Biotech Stocks Tha...
- UserRimp's Stockpicks
Latest GTXI Headlines from TheStreet
- 5 Health Care Stocks Under $10 Ready to Rip Higher 04.18.13 | 09:04 pm
- 4 Stocks Soaring on Unusual Volume 12.11.12 | 03:12 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 03:08 pm
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 5 Stocks Insiders Love Right Now 03.15.12 | 01:03 pm
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- GTx Stock Gaps Down On Today's Open (GTXI) 02.21.12 | 08:02 am
- 5 Stocks With Big Insider Buying 07.01.11 | 02:07 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
Press Releases for GTXI
- GTx-758 Poster Presentation Of Phase II Trial Data In Advanced Prostate Cancer Selected As One Of The Best Posters At The 28th Annual European Association Of Urology Congress - Business Wire 03.19.13 | 08:03 am
- Enobosarm Phase 2 Trial For Muscle Wasting And Physical Function In Patients With Cancer Published In The Lancet Oncology - Business Wire 03.14.13 | 07:03 am
- GTx Announces Webcast Of Corporate Presentation At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 07:02 am
- GTx Provides Corporate Update And Reports 2012 Financial Results - Business Wire 02.21.13 | 06:02 am
- GTx Announces Webcast Of Corporate Presentation At 2013 Citi Global Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- GTx To Present Preclinical Data On A New Therapeutic Target In Prostate Cancer - Business Wire 02.14.13 | 07:02 am
- Novel Findings From Clinical Studies Examining The Effects Of Capesaris® (GTx-758) For The Treatment Of Advanced Prostate Cancer To Be Presented At 2013 American Society Of Clinical Oncology Genitourinary Cancer Symposium - Business Wire 02.13.13 | 07:02 am
- GTx Announces Webcast For Capesaris®(GTx-758) Analyst Day - Business Wire 02.12.13 | 07:02 am
- GTx, Inc. To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.07.13 | 07:02 am
- GTx Announces Webcast Of Corporate Presentation At Bio CEO & Investor Conference - Business Wire 02.05.13 | 07:02 am
Partner Headlines for GTXI
- Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc. - GuruFocus 07.23.12 | 01:07 am
- 3 Rallying Stocks Under $5 Being Bought Up By Company Insiders - Seeking Alpha 07.22.12 | 09:07 am
- Analyzing GTx, Inc.'s Vast Upside Potential - Seeking Alpha 03.26.12 | 09:03 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Calls Purchased on GTx, Inc. - Benzinga 06.20.11 | 01:06 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- GTx Up Nearly 26% (GTXI) - Benzinga 04.13.11 | 09:04 am
- 20 Stocks Under $3 With Significant Insider Buying - Seeking Alpha 03.14.11 | 09:03 am
